Health Library

Q&A from Multiple Myeloma Patient Symposium: Ken Anderson, MD, and Paul Richardson, MD
Ken Anderson, MD, and Paul Richardson, MD, answer questions about multiple myeloma and its treatment.

A Patient's Perspective: James Bond and wife Kathy Bond
James Bond shares his experience being diagnosed with, treated for, and living with multiple myeloma during Dana-Farber's Multiple Myeloma Patient Symposium.

Current and Future Treatment of Multiple Myeloma: Kenneth C. Anderson, MD
Ken Anderson, MD, discusses current and future treatment for multiple myeloma during Dana-Farber's 202 Multiple Myeloma Patient Symposium.

Smoldering Multiple Myeloma: Irene Ghobrial, MD
Irene Ghobrial, MD, presents on smoldering myeloma and current work aimed at preventing progression to multiple myeloma during Dana-Farber's 2020 Multiple Myeloma Patient Symposium.

Diagnosis, Prognosis and Risk In Multiple Myeloma: Nikhil C. Munshi, MD
Nikhil Munshi, MD, presents the diagnosis and risk assessment in multiple myeloma at Dana-Farber's 202 Multiple Myeloma Patient Symposium.

New Directions in Treating Multiple Myeloma in the Era of Novel Agents: Paul G. Richardson, MD
Paul Richardson, MD, discusses new directions and novel agents for treating multiple myeloma at Dana-Farber's 2020 Multiple Myeloma Patient Symposium.

Updates on Managing Bone Disease in Multiple Myeloma: Andrew Yee, MD
Andrew Yee, MD, provides updates on managing bone disease for multiple myeloma patients during the 2020 Dana-Farber Multiple Myeloma Patient Symposium.

Cellular Immunotherapy for Multiple Myeloma: David Avigan, MD
David Avigan, MD, discusses how cellular immunotherapy can be used in treating multiple myeloma during the 2020 Dana-Farber Multiple Myeloma Patient Symposium.

Symptom Management in Multiple Myeloma: Kim Noonan, DNP, ANP-BC, AOCN
Kim Noonan, DNP, ANP-BC, AOCN, discusses symptom management for multiple myeloma patients at Dana-Farber's 2020 Multiple Myeloma Patient Symposium.